PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.81%
Positive revenue growth while ADI is negative. John Neff might see a notable competitive edge here.
3.64%
Positive gross profit growth while ADI is negative. John Neff would see a clear operational edge over the competitor.
4.17%
Positive EBIT growth while ADI is negative. John Neff might see a substantial edge in operational management.
5.51%
Positive operating income growth while ADI is negative. John Neff might view this as a competitive edge in operations.
9.20%
Positive net income growth while ADI is negative. John Neff might see a big relative performance advantage.
10.14%
Positive EPS growth while ADI is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
9.56%
Positive diluted EPS growth while ADI is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.21%
Share reduction while ADI is at 0.08%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.31%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.08%
Dividend growth under 50% of ADI's 0.21%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
10.91%
Positive OCF growth while ADI is negative. John Neff would see this as a clear operational advantage vs. the competitor.
21.89%
Positive FCF growth while ADI is negative. John Neff would see a strong competitive edge in net cash generation.
75.75%
10Y revenue/share CAGR at 50-75% of ADI's 137.23%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
22.11%
5Y revenue/share CAGR under 50% of ADI's 72.93%. Michael Burry would suspect a significant competitive gap or product weakness.
9.87%
3Y revenue/share CAGR under 50% of ADI's 41.47%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
220.59%
10Y OCF/share CAGR in line with ADI's 226.21%. Walter Schloss would see both as similarly efficient over the decade.
63.29%
5Y OCF/share CAGR at 50-75% of ADI's 120.10%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
50.95%
3Y OCF/share CAGR at 50-75% of ADI's 80.80%. Martin Whitman would suspect weaker recent execution or product competitiveness.
255.52%
Net income/share CAGR at 75-90% of ADI's 336.51%. Bill Ackman would press for strategic moves to boost long-term earnings.
95.58%
5Y net income/share CAGR 1.25-1.5x ADI's 70.59%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
57.62%
3Y net income/share CAGR above 1.5x ADI's 30.71%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
27.78%
Below 50% of ADI's 278.18%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-2.72%
Negative 5Y equity/share growth while ADI is at 100.20%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-6.47%
Negative 3Y equity/share growth while ADI is at 96.64%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
601.27%
10Y dividend/share CAGR above 1.5x ADI's 170.78%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
156.24%
5Y dividend/share CAGR above 1.5x ADI's 46.52%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
102.09%
3Y dividend/share CAGR above 1.5x ADI's 28.95%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-5.43%
Firm’s AR is declining while ADI shows 0.58%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-1.88%
Inventory is declining while ADI stands at 4.97%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
3.50%
Positive asset growth while ADI is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
6.11%
BV/share growth above 1.5x ADI's 0.33%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-0.19%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-2.82%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-5.00%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.